ClinicalTrialsFinder

Pulmonary Pleomorphic Carcinoma Clinical Trials in Nanchang, Jiangxi

1 recruitingNanchang, Jiangxi, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Phase II, Single-arm Exploratory Clinical Study of Tislelizumab Combined With Anlotinib in the Treatment of Advanced Pulmonary Pleomorphic Carcinoma

ImmunotherapyTislelizumabPulmonary Pleomorphic Carcinoma
Second Affiliated Hospital of Nanchang University32 enrolled1 locationNCT05375734